Tumor cell lysates as immunogenic sources for cancer vaccine design
/in Dendritic Cells, International PublicationsAntigen trapping by dendritic cells for antitumor therapy
/in Dendritic Cells, International PublicationsGeneration of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine
/in Dendritic Cells, International PublicationsImmunotherapy and lung cancer: current developments and novel targeted therapies
/in Dendritic Cells, International Publications, NSCLCAutologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function
/in Colorectal Cancer, Dendritic Cells, International Publications, IOZK VeröffentlichungenDendritic cell-based vaccines: clinical applications in breast cancer
/in Breast Cancer, Dendritic Cells, International PublicationsNovel dendritic cell-based vaccination in late stage melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaDendritic cell immunotherapy in uterine cancer
/in Dendritic Cells, Endometrial Cancer, International PublicationsDendritic cells in cancer immunotherapy clinical trials: are we making progress?
/in Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer